TL;DR
This study reveals that a significant portion of acute myocardial infarction (AMI) patients in Asia present without traditional risk factors (hypertension, diabetes, high cholesterol, smoking) but experience worse short-term outcomes, including higher cardiovascular mortality and cardiogenic shock. This highlights a critical need for increased clinical attention and tailored management strategies for this "SMuRF-less" subgroup.
What Problem Does This Paper Address?
Cardiovascular disease prevention and management have historically focused on individuals with identifiable, "standard modifiable risk factors" (SMuRFs) like hypertension, hypercholesterolemia, diabetes, and smoking. However, recent observations suggest a growing number of patients experiencing acute myocardial infarction (AMI) without these established risk factors. These "SMuRF-less" patients, while often younger and with fewer comorbidities, have been an understudied group, particularly in Asian populations. Previous research has hinted at potentially worse outcomes for these individuals, but a comprehensive understanding of their prognostic trajectory, especially in a multiethnic Asian context, was lacking. This paper aims to fill that gap by characterizing the prevalence, clinical features, and outcomes of SMuRF-less AMI patients compared to those with SMuRFs.
Methods
The researchers conducted a retrospective observational study on a large cohort of 8,680 patients who presented with AMI at a major tertiary academic hospital in Singapore between 2011 and 2021. Patients were categorized into two groups: SMuRF (having one or more standard modifiable risk factors) and SMuRF-less (having none).
Key methodological aspects include:
- Data Collection: Retrospective collection of demographic, clinical, angiographic, procedural, and medication data from electronic health records.
- Outcome Assessment: Primary outcome was 30-day cardiovascular mortality. Secondary outcomes included 30-day all-cause mortality, unplanned cardiac readmission, cardiogenic shock, heart failure, and stroke.
- Statistical Analysis:
- Baseline Characteristics: Chi-squared tests or Fisher's exact tests for categorical variables, and two-sample t-tests for continuous variables.
- Outcome Analysis: * 30-day Cardiovascular Mortality: Analyzed using a Fine-Gray model to account for competing risks.
- Other Binary Outcomes: Generalized linear regression with a log link and Gaussian distribution, using robust variance estimators to compute risk ratios (RRs).
- Multivariable Analysis: Adjusted for age, sex, ethnicity, chronic kidney disease, AMI type (STEMI/NSTEMI), cardiac arrest, and the presence of left main or left anterior descending coronary artery disease.
- Survival Analysis: Kaplan-Meier curves were used to visualize 30-day cardiovascular mortality and 10-year all-cause mortality, with stratification by ethnicity, gender, and AMI type.
Datasets
The study utilized a dataset of 8,680 consecutive patients presenting with AMI to a major tertiary academic hospital in Singapore between January 1, 2011, and March 31, 2021. This dataset was derived from the hospital's electronic clinical records. No new datasets were introduced.
Key Insights and Ideas
- Unexpectedly High-Risk Group: The most striking insight is that patients presenting with AMI without traditional risk factors (SMuRF-less) are not necessarily "low-risk." Despite being younger and having fewer comorbidities, they exhibit significantly worse short-term outcomes.
- Different Clinical Presentation: SMuRF-less patients presented with a higher incidence of ventricular arrhythmias and a greater need for inotropic support and invasive ventilation, suggesting a more critical state upon arrival.
- Ethnic Disparities: While the study focused on an Asian population, it highlighted significant ethnic variations within this group, with Indian patients showing a higher proportion of SMuRF-less AMI cases, suggesting potential genetic predispositions.
- Sex Differences in Outcomes: Short-term mortality was higher in male SMuRF-less patients, but not in females, possibly due to differences in age and AMI type presentation between sexes in this cohort.
- Medication Adherence: SMuRF-less patients were less likely to be prescribed guideline-directed medications like ACE inhibitors or ARBs, potentially due to a misperception of lower risk, which could contribute to poorer outcomes.
Key Results
- Prevalence: SMuRF-less patients constituted 8.6% of the study cohort (746 out of 8,680). The yearly prevalence of SMuRF-less AMI patients remained relatively stable between 5.9% and 10.7% from 2011 to 2021.
- Demographics: SMuRF-less patients were significantly younger (mean age 57 vs. 61 years) and had a lower prevalence of stroke and chronic kidney disease.
- Outcomes:
- Cardiovascular Mortality: Significantly higher in SMuRF-less patients (10.7% vs. 6.1% overall; adjusted HR 1.48).
- All-Cause Mortality: Significantly higher in SMuRF-less patients (11.7% vs. 5.5% overall; sustained for up to 5 years).
- Cardiogenic Shock: Significantly higher in SMuRF-less patients (12.7% vs. 7.2% overall; adjusted RR 1.31).
- Stroke: Significantly higher in SMuRF-less patients (adjusted RR 2.51).
- Readmission and Heart Failure: Similar between the two groups.
- Survival Curves: Kaplan-Meier curves showed significantly higher 30-day cardiovascular mortality in the SMuRF-less group, particularly in men and STEMI patients, and across all three Asian ethnicities studied (Chinese, Malay, Indian). Long-term all-cause mortality showed an initial separation but converged around the 5-year mark.
Limitations and Future Work
Limitations:
- Retrospective Design: The study is retrospective and observational, limiting the ability to establish causality and potentially subject to unknown confounders and biases.
- SMuRF/SMuRF-less Dichotomy: Categorizing patients into these two groups might oversimplify complex risk profiles and miss individuals with borderline risk factors.
- Unaccounted Risk Factors: The study acknowledges that other recognized risk factors (e.g., obesity, triglyceride levels, HDL, sedentary lifestyle, psychosocial factors, dietary habits, alcohol consumption) were not fully evaluated. Non-atherosclerotic causes of AMI (e.g., protein C and S deficiency) were also not assessed.
- Single-Center Study: While large, it is a single-center study, which may limit generalizability to other healthcare systems.
Future Work:
- Broader Risk Factor Evaluation: Further research is needed to explore the role of less established risk factors and non-atherosclerotic causes of AMI in the SMuRF-less population.
- Genetic Predisposition: Given the ethnic variations observed, future studies should investigate the genetic underpinnings of AMI in SMuRF-less individuals.
- Long-Term Outcomes: While this study provided some long-term data, more extensive longitudinal studies are needed to fully understand the long-term prognosis of SMuRF-less patients.
- NSTEMI Subgroup: The study noted differences in outcomes between STEMI and NSTEMI patients within the SMuRF-less group, suggesting a need for more focused research on SMuRF-less NSTEMI patients.
- Intervention Strategies: Development and testing of tailored preventative and treatment strategies for this high-risk subgroup are crucial.
Summary updated